On December 5, Senators Warren and Grassley sent a letter to the Acting FDA Commissioner, Brett Giroir, MD, pointing out the fact that the FDA previously announced that over-the-counter (OTC) hearing aid rules would be a priority on their fall 2018 Unified Agenda and they would likely deliver the proposed rules well in advance of the August 2020 statutory deadline. Senators Warren and Grassley note that “it is now December 2019 and we have yet to see these regulations come to fruition.”
Citing the serious nature of hearing difficulties and the related conditions that frequently accompany them, the letter requests that the FDA provide an update on the status of the OTC hearing aid rules and regulations and when the FDA expects to finalize the OTC hearing aid rules no later than December 19, 2019.
Recent Posts
Academy Files Rulemaking Petition to Restore ABA Language in VA Regulations
Earlier last year, the Virginia Board of Audiology and Speech-Language Pathology finalized regulatory changes intended to streamline licensure by removing direct ties between certification and…
Congress Needs to Hear From Audiologists on Student Loan Access
The Professional Student Degree Act, H.R. 6718, introduced by Representative Michael Lawler (R-NY), was introduced in mid-December. This bill reaffirms audiology’s status as a professional…
Why Wild Animals Don’t Have Floppy Ears
In 1959, a scientist began a domestication experiment with silver foxes. Critics believed the experiment was, at the very least, too ambitious (if not outright…
